Jobs with Startups
JobsStartupsInvestorsMCP
Startups

ElevateBio

ElevateBio logo

ElevateBio

elevate.bio
HQ: Waltham, Massachusetts, United States
500
Biotechnology & Agriculture

Company research

Public company, workplace, funding, and market signals

Updated Aug 16, 2026

Overview

ElevateBio is a technology-driven genetic-medicine company that combines proprietary gene-editing and cell-engineering technologies with end-to-end process development and cGMP manufacturing. It partners with biopharmaceutical companies from discovery through commercialization through its Life Edit and BaseCamp businesses.

Primary product

Integrated genetic-medicine platform: Life Edit gene-editing technologies and R&D plus BaseCamp process development and cGMP manufacturing services for cell therapies, gene therapies, viral vectors, mRNA, and related modalities.

Founded

2017

Headquarters

200 Smith Street, Waltham, Massachusetts 02451, United States

Team size

300-400; third-party sources have reported approximately 342 employees, while the company reported just under 400 after its March 2025 reduction.

Industry

Biotechnology and pharmaceutical manufacturing

Sub-industry

Cell and gene therapy CDMO; genetic-medicine technology platforms; gene editing

Offices

200 Smith Street, Waltham, MA 02451 — corporate headquarters and BaseCamp Waltham
225 Wyman Street, Waltham, MA — process-development laboratories and corporate offices
46 Beehive Street, Suite 201, Pittsburgh, PA 15207 — BaseCamp Pittsburgh, under construction
300 Morris Street, Suite 300, Durham, NC 27701 — gene-editing and R&D site

Business model

B2B contract development and manufacturing services
Technology licensing and strategic partnerships
Sponsored research and development collaborations
Milestone and royalty-based therapeutic partnerships
Selective internal therapeutic development

Funding

Stage

Series D; private, revenue-generating company

Total raised

$1.2B

Latest round

Series D · May 2023

Latest amount

$401M

Series D

May 2023 · AyurMaya Capital Management Fund, managed by Matrix Capital Management

$401M

Series C

Mar 2021 · Matrix Capital Management

$525M

Series B

Mar 2020 · The Invus Group

$170M

Series A

May 2019 · UBS Oncology Impact Fund

$150M

People & investors

Leadership

Christopher Murphy

Chief Executive Officer and Board Member

Bhakti Bhargava

Chief Financial Officer

Larry Lockwood

Chief Commercial Officer

Amy Pooler

Chief Scientific Officer

Michael Paglia

Chief Technology Officer

Catherine Hu

SVP, Corporate Affairs and Chief of Staff

Missy Kotchey

SVP, Head of People and Culture

Aaron Nudelman

SVP, Head of Intellectual Property

David Hallal

Executive Chairman, ElevateBio Board of Directors; Co-founder

Ger Brophy

Strategic Advisor and former Interim Chief Executive Officer

Founders

Mitchell Finer

Co-founder

Vikas Sinha

Co-founder; former Chief Financial Officer; Board Member

Investors

EcoR1 Capital
EDBI
Emerson Collective
F2 Ventures / F2 Capital
Fidelity Management & Research Company
Itochu Corporation
Lee Family Office
Matrix Capital Management / AyurMaya Capital Management Fund
MPM Capital / MPM BioImpact
Novo Nordisk
Redmile Group
Samsara BioCapital
SoftBank Vision Fund 2
Surveyor Capital, a Citadel company
The Invus Group
UBS Oncology Impact Fund
Vertex Ventures
Woodline Partners

Work & culture

The company describes its culture as a community of explorers focused on discovery, technology, progress, and accelerating life-transforming therapies. Its careers materials emphasize cross-functional collaboration, continuous learning, and five culture principles, although the specific principles were not consistently exposed in search excerpts.

Visa sponsorship

Limited

Compensation

Public job postings provide role-specific ranges in some cases; one Pittsburgh quality internship listed $25 per hour. Public Department of Labor aggregation indicates a history of H-1B filings, with a reported median sponsored salary of approximately $95,000 and filings concentrated in Waltham and Durham. Glassdoor estimates compensation ranging from about $46,000 for manufacturing associates to approximately $303,000 for vice presidents, but these are third-party estimates rather than company-confirmed ranges.

Benefits

Medical, vision, and dental insurance with 90% employer coverage
Low-deductible mental-health coverage with no in-network copays or coinsurance
Annual fitness reimbursement
Employer-paid wellness applications and programs
401(k) with 4% employer match and no vesting period
Employer-paid life insurance and short- and long-term disability insurance
FSA and dependent-care accounts
One-on-one financial-advisor access
Commuter reimbursement
Monthly cell-phone stipend
Paid time off, sick time, family leave, and bereavement leave
12 weeks of parental leave
Insights Discovery training
Manager training and professional-development programs
LinkedIn Learning access

Product & market

Pricing

Custom, program-specific pricing; public evidence indicates negotiated contracts for discovery, process development, technology transfer, cGMP manufacturing, licensing, milestones, royalties, and—in some partnerships—profit sharing. No public standard price list was found.

Differentiators

  • —Combines gene-editing discovery and design with process development and cGMP manufacturing in one ecosystem
  • —Life Edit provides a broad gene-editing toolbox spanning nucleases, base editors, reverse-transcriptase editors, targeted insertion, and epigenetic editing
  • —BaseCamp supports programs from early development through clinical and commercial manufacturing
  • —Same organization can support design, analytical development, process development, quality, technology transfer, and manufacturing
  • —Investment in automation, AI-assisted design, protein-language models, and advanced analytics
  • —BaseCamp Waltham received ICMC certification across viral gene delivery, nonviral gene delivery, and cell-therapy manufacturing
  • —Company reports a 98% manufacturing batch-success rate across cell therapy, viral-vector, and mRNA programs in 2025
  • —Commercial partners can access sponsor visibility, partner-in-plant participation, and real-time batch information

Technology

CRISPR nuclease editing
Base editing
Reverse-transcriptase editing
Targeted gene insertion
Epigenetic editing
Generative AI and protein-language models
Proprietary CRISPR and protein databases
RNA engineering
Cell engineering
iPSC technology
LentiPeak lentiviral-vector platform
AAV and nonviral delivery
Lipid nanoparticles
Automation and advanced analytics
cGMP cell therapy manufacturing
cGMP viral-vector manufacturing
mRNA manufacturing

Customers

Moderna
Novo Nordisk
Beam Therapeutics
Affini-T Therapeutics
More than 20 biopharmaceutical and technology partners reported in 2024
Academic and research partners, including the University of Pittsburgh and California Institute for Regenerative Medicine

Competitors

CRISPR Therapeutics
Bluebird Bio
Forge Biologics
Regenxbio
Catalent
Charles River Laboratories
Andelyn Biosciences
Resilience
AGC Biologics
Ori Biotech

Scale & contact

Estimated revenue

Approximately $100M-$500M annually. CNBC reported $120M of 2024 revenue, while third-party company-data sources estimate approximately $437M; the discrepancy reflects limited private-company disclosure and differing methodologies.

Estimated monthly visits

25.5K

Traffic estimate as of Jun 2026

Signals & risks

Layoff
Oct 2023

Following the May 2023 Series D, ElevateBio announced a 13% workforce reduction and reduced some early preclinical work, focusing resources on BaseCamp manufacturing and the Life Edit gene-editing platform.

Source
Layoff
Oct 2024

Endpoints News reported an additional workforce reduction of approximately 4% in October 2024, when the company had roughly 500 employees.

Source
Layoff
Mar 2025

The company confirmed a further 17% workforce reduction, bringing employment to just under 400. Management cited biotech-sector headwinds, organizational simplification, and concentration on high-impact BaseCamp and Life Edit capabilities.

Source
Acquisition
Jan 2021

ElevateBio acquired genome-editing company Life Edit Therapeutics, formerly Beam Therapeutics' gene-editing unit, for an undisclosed amount. Life Edit is now a core ElevateBio business.

Source
Other
Apr 2025

Founder and long-serving CEO David Hallal transitioned to Executive Chairman; Vikas Sinha stepped down as CFO and Bhakti Bhargava became CFO. Ger Brophy subsequently served as interim CEO before Christopher Murphy became CEO in January 2026.

Source

Latest news

ElevateBio Achieves Sixth Consecutive Year of Revenue Growth Driven by Expansion of Its Genetic-Medicine Technology and Manufacturing Business

ElevateBio · Jan 2026

The company reported a sixth consecutive year of revenue growth, 18 supported preclinical and clinical programs, a 98% manufacturing batch-success rate, a 30% expansion of Waltham manufacturing capacity, and continued construction of BaseCamp Pittsburgh.

ElevateBio Appoints Christopher Murphy as Chief Executive Officer and Member of the Board of Directors

ElevateBio · Jan 2026

Christopher Murphy became CEO, succeeding interim CEO Ger Brophy. Brophy remains an advisor on strategy and technology.

ElevateBio BaseCamp Achieves ICMC Certification for Commercial Cell and Gene Therapy Manufacturing Capabilities

ElevateBio · Aug 2025

BaseCamp Waltham became the first genetic-medicine manufacturing business reported to have ICMC certification across viral gene delivery, nonviral gene delivery, and cell-therapy products.

Despite Raising $1B Over Past 5 Years, ElevateBio Lets Go of 17% of Workforce

Fierce Biotech · Mar 2025

ElevateBio confirmed a 17% workforce reduction, its third reported reduction since 2023, citing organizational simplification and prioritization of BaseCamp and Life Edit.

ElevateBio Collaborates with AWS to Broaden the Potential of CRISPR Gene-Editing Therapies with Generative AI

ElevateBio · Mar 2025

ElevateBio and AWS announced a multi-year collaboration using AWS cloud infrastructure, SageMaker, protein-language models, and Life Edit data to accelerate discovery and optimization of CRISPR systems.

AboutBaseCamp manufacturing and discovery servicesCareersCompany websiteCurrent jobs / Greenhouse boardElevated Insights engineering/science blogFacilitiesLife Edit gene-editing R&DTeam / leadershipTechnology platforms
SourcesElevateBio About UsElevateBio FacilitiesElevateBio TeamElevateBio Careers and BenefitsElevateBio Technology PlatformsElevateBio CDMO ServicesElevateBio Investors and Press ReleasesElevateBio Series D announcementCNBC 2025 Disruptor 50 profileReuters Series D coverageElevateBio 2026 business update

Jobs and careers at ElevateBio

13 jobs at ElevateBio

Senior Director, Communications

On-site
Waltham, Massachusetts, United States
2d ago
On-site
Full-time
Apply

Senior Manager, QC Technical Operations

On-site
Quality Control
Waltham, Massachusetts, United States
4d ago
On-site
Full-time
Apply

Senior Manager, Manufacturing

On-site
Manufacturing
Waltham, Massachusetts, United States
4d ago
On-site
Full-time
Apply

Scientist I, mRNA, Process Development

On-site
Process Development
Waltham, Massachusetts, United States
1w ago
On-site
Full-time
Apply

Biomanufacturing Associate II (Contract, Mon-Fri)

On-site
Manufacturing
Waltham, Massachusetts, United States
1w ago
On-site
Full-time
Apply

Specialist I, Materials Management (Contract)

On-site
Waltham, Massachusetts, United States
2w ago
On-site
Full-time
Apply

Engineer I, MSAT

On-site
MSAT
Pittsburgh, Pennsylvania, United States; Waltham, Massachusetts, United States
2w ago
On-site
Full-time
Apply

Associate I-II, QC Analytics (Contract, Multiple Positions)

On-site
Quality Control
Waltham, Massachusetts, United States
1mo ago
On-site
Full-time
Apply

Engineer II, Facilities

On-site
Facilities and Engineering
Waltham, Massachusetts, United States
1mo ago
On-site
Full-time
Apply

Senior Manager, Metrology

On-site
Facilities and Engineering
Waltham, Massachusetts, United States
1mo ago
On-site
Full-time
Apply

Lead, Maintenance Technician

On-site
Facilities and Engineering
Pittsburgh, Pennsylvania, United States; Waltham, Massachusetts, United States
1mo ago
On-site
Full-time
Apply

Senior Scientist, LNP, Process Development & Manufacturing

On-site
Process Development
Waltham, Massachusetts, United States
1mo ago
On-site
Full-time
Apply

Not seeing what you're looking for? Join Our Talent Community!

On-site
United States
5mo ago
On-site
Full-time
Apply

Explore startup hiring

Startup Hiring PulseBrowse all startup jobsJobs at venture-backed startups

Jobs with Startups © 2026

Browse jobsMCP guideAboutPowered by Supabase